191 related articles for article (PubMed ID: 24328486)
21. Cystic fibrosis transmembrane conductance regulator dysfunction and its treatment.
Hull J
J R Soc Med; 2012 Jun; 105 Suppl 2(Suppl 2):S2-8. PubMed ID: 22688363
[No Abstract] [Full Text] [Related]
22. Targeting the basic defect in cystic fibrosis.
Welsh MJ
N Engl J Med; 2010 Nov; 363(21):2056-7. PubMed ID: 21083391
[No Abstract] [Full Text] [Related]
23. Aquagenic wrinkling of the palms in an adult cystic fibrosis population.
Tolland JP; Boyle J; Hall V; McKenna KE; Elborn JS
Dermatology; 2010; 221(4):326-30. PubMed ID: 20881360
[TBL] [Abstract][Full Text] [Related]
24. Breathing easier with combinations.
Azvolinsky A
Nat Biotechnol; 2015 Nov; 33(11):1128-30. PubMed ID: 26544137
[No Abstract] [Full Text] [Related]
25. [Aquagenic palmoplantar keratoderma in children with cystic fibrosis].
Weil B; Chaillou E; Troussier F; Pelatan C; Chiffoleau M; Darviot E; Chevalier MC; Martin L; Giniès JL
Arch Pediatr; 2013 Dec; 20(12):1306-9. PubMed ID: 24210985
[TBL] [Abstract][Full Text] [Related]
26. Therapy for cystic fibrosis--the end of the beginning?
Davis PB
N Engl J Med; 2011 Nov; 365(18):1734-5. PubMed ID: 22047565
[No Abstract] [Full Text] [Related]
27. Potentiators for cystic fibrosis - targeting the underlying molecular defect.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Paediatr Respir Rev; 2015 Jun; 16(3):162-4. PubMed ID: 26002404
[No Abstract] [Full Text] [Related]
28. Aquagenic wrinkling of the palms and cystic fibrosis: an Italian study with controls and genotype-phenotype correlations.
Chinazzo C; De Alessandri A; Menoni S; Romanisio G; Rebora A; Rongioletti F
Dermatology; 2014; 228(1):60-5. PubMed ID: 24434749
[TBL] [Abstract][Full Text] [Related]
29. Mutation-specific therapy in cystic fibrosis: the earlier, the better.
Tümmler B
Lancet Respir Med; 2013 Oct; 1(8):591-592. PubMed ID: 24461654
[No Abstract] [Full Text] [Related]
30. Cystic fibrosis drug Vertex's latest triumph.
Ledford H
Nat Biotechnol; 2012 Mar; 30(3):201-2. PubMed ID: 22398597
[No Abstract] [Full Text] [Related]
31. Intestinal Current Measurements Detect Activation of Mutant CFTR in Patients with Cystic Fibrosis with the G551D Mutation Treated with Ivacaftor.
Graeber SY; Hug MJ; Sommerburg O; Hirtz S; Hentschel J; Heinzmann A; Dopfer C; Schulz A; Mainz JG; Tümmler B; Mall MA
Am J Respir Crit Care Med; 2015 Nov; 192(10):1252-5. PubMed ID: 26568242
[No Abstract] [Full Text] [Related]
32. Treating Specific Variants Causing Cystic Fibrosis.
Cutting GR
JAMA; 2017 Dec; 318(21):2130-2131. PubMed ID: 29209709
[No Abstract] [Full Text] [Related]
33. [Causal therapy is available].
Meißner T
MMW Fortschr Med; 2016 Jun; 158(12):74. PubMed ID: 27324018
[No Abstract] [Full Text] [Related]
34. Excitement mounts for first disease-modifying cystic fibrosis drugs.
Opar A
Nat Rev Drug Discov; 2011 Jul; 10(7):479-80. PubMed ID: 21720393
[No Abstract] [Full Text] [Related]
35. Females with Cystic Fibrosis Demonstrate a Differential Response Profile to Ivacaftor Compared with Males.
Secunda KE; Guimbellot JS; Jovanovic B; Heltshe SL; Sagel SD; Rowe SM; Jain M
Am J Respir Crit Care Med; 2020 Apr; 201(8):996-998. PubMed ID: 31841644
[No Abstract] [Full Text] [Related]
36. PharmGKB summary: ivacaftor pathway, pharmacokinetics/pharmacodynamics.
Fohner AE; McDonagh EM; Clancy JP; Whirl Carrillo M; Altman RB; Klein TE
Pharmacogenet Genomics; 2017 Jan; 27(1):39-42. PubMed ID: 27636560
[No Abstract] [Full Text] [Related]
37. Sweat chloride is not a useful marker of clinical response to Ivacaftor.
Barry PJ; Jones AM; Webb AK; Horsley AR
Thorax; 2014 Jun; 69(6):586-7. PubMed ID: 24258833
[TBL] [Abstract][Full Text] [Related]
38. A combination therapy for cystic fibrosis.
Brodsky JL; Frizzell RA
Cell; 2015 Sep; 163(1):17. PubMed ID: 26406363
[TBL] [Abstract][Full Text] [Related]
39. A cocktail drug therapy for patients with cystic fibrosis?
Chen JH
J Cyst Fibros; 2014 Sep; 13(5):489-90. PubMed ID: 25088968
[No Abstract] [Full Text] [Related]
40. Personalized medicine. New cystic fibrosis drug offers hope, at a price.
Kaiser J
Science; 2012 Feb; 335(6069):645. PubMed ID: 22323790
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]